Re: Chao-Yu Hsu, Steven Joniau, Raymond Oyen et al. Outcome of Surgery for Clinical Unilateral T3a Prostate Cancer: A Single-Institution Experience. Eur Urol 2007;51:121–9
文摘
A 69-yr-old man with bilateral and metastatic renal cell carcinoma developed progressive disease after interleukin-2 and interferon therapy. He was submitted to radical left nephrectomy, right nephron-sparing surgery, and bone metastasis removal, followed by therapy with sorafenib. At 12-mo follow-up there was a significant improvement in patient performance status and no evidence of clinical progression.